Company / Net Income
Zimmer Biomet Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$705.1M
FY2025
5-year range
$231.4M / $1.0B
FY2021-FY2025
Trend
-22.0%
vs FY2024
Sector context
#33 of 164
Health Care
What the data says
Zimmer Biomet's net income of $705M is higher than 80% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$139M in FY2020 to $1.8B in FY2019.
Based on SEC 10-K filings.
$705M in FY2025 with a 3-year CAGR of +45.0%. Top quartile in the Health Care sector.
Declined from $1.0B to $705M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +45.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 164This company $705.1M Sector average $467.2M
▼
+50.9% above sector average
Key checks
Key Insights
- 3-year CAGR of +45.0%, indicating consistent growth.
- In FY2025, net income decreased 22.0% year-over-year.
- Ranks #33 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $705.1M | -22.0% |
| FY2024 | $903.8M | -11.7% |
| FY2023 | $1.0B | +342.5% |
| FY2022 | $231.4M | -42.4% |
| FY2021 | $401.6M | +389.1% |
| FY2020 | -$138.9M | -107.7% |
| FY2019 | $1.8B | +492.9% |
| FY2018 | $305.9M | -83.1% |
| FY2017 | $1.8B | +151.8% |
| FY2016 | $720.3M | +390.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026